Literature DB >> 22326232

Stability of binary model membranes--prediction of the liposome stability by the Langmuir monolayer study.

A Szcześ1, M Jurak, E Chibowski.   

Abstract

In this paper, usefulness of the Langmuir monolayer study is demonstrated for predictions of the stability of liposomes composed of dipalmitoyl phosphatidylcholine (DPPC) and cholesterol (Chol). Thermodynamic analysis of the surface pressure (π)-area (A) isotherms of the DPPC/Chol systems was performed, which allowed for concluding on miscibility of the components, their molecular packing, and the interactions between molecules. It was found that the most stable system, in which the strongest interactions between molecules occured, was DPPC/Chol at x(Chol)=0.25. The stability of liposomes of the same composition as that in the Langmuir monolayers was analyzed by determining the size distribution of vesicles and the polydispersity as a function of time. The changes of these parameters confirmed that the system of the greatest stability is that with low Chol content.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326232     DOI: 10.1016/j.jcis.2012.01.035

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  2 in total

Review 1.  Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications.

Authors:  Anjana Jeyaram; Steven M Jay
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

2.  The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes.

Authors:  Yoelys Cruz-Leal; Daniel Grubaugh; Catarina V Nogueira; Isbel Lopetegui-González; Anaixis Del Valle; Felipe Escalona; Rady J Laborde; Carlos Alvarez; Luis E Fernández; Michael N Starnbach; Darren E Higgins; María E Lanio
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.